choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Kaletra

Kaletra Newsletter
  • Ibrance interactions: Alcohol, medications, and other factors 31 Mar 2025 15:48 GMT

    … HIV drugs that may interact with Ibrance: lopinavir/ritonavir (Kaletra) saquinavir … your doctor if you take HIV medications before you start Ibrance treatment. They … your doctor or another healthcare professional before taking any medication. The drug

  • Elahere interactions: Alcohol, medications, and other factors 20 Mar 2025 17:45 GMT

    … ritonavir (Norvir) lopinavir/ritonavir (Kaletra) cobicistat/elvitegravir/emtricitabine … Elahere treatment, let your doctor know if you take HIV medications. Your doctor can … warning from the Food and Drug Administration (FDA). If you have existing …

  • HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR 18 Mar 2025 11:28 GMT

    trials for its next-generation HIV treatment targeting drug- … HIV Treatments Reducing the need for daily pills, improving … precision medicine for HIV AbbVie Inc. Aluvia, Kaletra Expanding … on affordable HIV treatment Teva Pharmaceutical Industries Ltd. Generic …

  • Xhance interactions: Alcohol, medications, and other factors 25 Feb 2025 17:19 GMT

    … described in detail in “Drug interactions in depth.” In … your doctor decide that you’ll start treatment with both medications, they … /ritonavir (Kaletra) Steps you or your doctor may take: Tell … ’t been enough clinical trials to determine whether Xhance …

  • Rosuvastatin oral tablet interactions: Alcohol, medications, and other factors 10 Feb 2025 21:04 GMT

    … #47;ritonavir (Kaletra) Steps you or your doctor may take The … ’s very similar to statins such as rosuvastatin. If … during treatment. There haven’t been enough clinical trials to … doctor or another healthcare professional before taking any medication. The drug

  • HIV Treatment Information for Pregnant Women 30 Jan 2025 20:04 GMT

    … -associated resistance substitutions. • Once daily KALETRA dosing is not recommended in … Populations (8.1)].   Pharmacokinetics: Pregnancy   Kaletra Label Odefsey* emtricitabine 200 mg … information available for the approved treatment dose of 600 mg twice …

  • ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter 15 Nov 2024 22:16 GMT

    Approval Date Reference Listed Drug Generic Drug Name NDA Holder … Endari L-Glutamine  Emmaus Medical Novitium Pharma 215647 07… #47;25/2024 Kaletra Lopinavir and Ritonavir   AbbVie … 2024 Tarceva Erlotinib HCl OSI Pharmaceuticals Hikma 203843 09…

  • Aristada interactions: Alcohol, medications, and other factors 09 Sep 2024 15:41 GMT

    drugs, and certain supplements. Examples include benzodiazepines and certain antidepressantsKaletra (lopinavir/ritonavir) Steps you or your doctor … : Treatment with … doctor or another healthcare professional before taking any medication. The drug

  • USPTO Publishes Drug Patent and Exclusivity Study Report 25 Jun 2024 01:18 GMT

    … conjunction with the Food and Drug Administration (FDA) and in response to … development of innovative medicines and the availability of generic drugs and addresses … fixed dose combination drug (e.g., lopinavir/ritonavir (KALETRA)); a new …

  • HIV Drugs Market Size Is Set to Grow by USD 10.47 Billion From 2023-2027 23 Apr 2024 16:49 GMT

    … Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., … effective treatment with HIV medications. Key Market Drivers The HIV drugs market … such as Kaletra and Norvir. The use of these drugs is essential …

Satisfied with the content?

Continue to create your account.